Patient Care Funding Waiting Lists Emergency Services Staffing Issues Waiting Times Public Health Strikes NHS England Staffing Performance Metrics Labor Relations Hospital Management Industrial Action Management Government Policy Emergency Care Healthcare Reform Health Policy Reforms Funding Issues Patient Experience Vaccination Programs Operational Challenges Workforce Winter Pressures Healthcare Management NHS Trusts Policy Changes Workforce Management Hospital Services Reform Medical Workforce Crisis Management Doctor Strikes Cancer Care Patient Safety Medical Professionals Healthcare Workforce Financial Management Patient Rights Cancer Treatment Healthcare Challenges Ambulance Services General Practice Appointments Public Health Policy Patient Services Social Care Healthcare Policy Doctors Policy Patient Statistics Trusts Healthcare Services Leadership GP Services NHS Funding NHS Reforms Hospital Admissions Impact of Strikes Government Funding Workforce Issues Patient Access Hospital Performance Performance Healthcare System Healthcare Funding Digital Health Prescription Charges Guidelines Healthcare Workers Scotland NHS Services Junior Doctors Systemic Issues Statistics Doctor Salaries Prescriptions Government Initiatives NHS Workforce Patient Satisfaction Patient Treatment Infrastructure Cancer Services Community Care Patient Support Hospital Trusts Pay Disputes Service Delivery Diagnostic Services NHS Staff Government Response Doctor Employment Winter Preparedness Policies Nursing Flu Patient Advocacy Hospitalization
NHS England plans to offer ruxolitinib to nearly 100,000 eligible people within about three months after striking a deal with Incyte.
